Press Release Summary: Titled “Russian Pharma Sector Analysis (2007)”, the report provides an extensive research and objective analysis on the growing demand of pharmaceuticals in the country and presents a clear picture of its healthcare and pharmaceutical market.
Press Release Body: The leading market research firm RNCOS has recently released its new report on the thriving pharmaceutical market of Russia. Titled “Russian Pharma Sector Analysis (2007)”, the report provides an extensive research and objective analysis on the growing demand of pharmaceuticals in the country and presents a clear picture of its healthcare and pharmaceutical market.
Market Analysis
The Russian pharmaceutical market, in 2006, witnessed one of the strongest growths globally with both the state and commercial segments registering double-digit growth in their sales value. The major impetus for growth was given by the Government’s Drug reimbursement program, which saw the consumption value of drugs increased by nearly 74% in 2006.
The commercial drugs market, driven by factors such as an ageing population, an increasing demand for imported and expensive medicines, an obligatory health insurance system and increasing disposable incomes, accounts for nearly half of the total pharmaceutical market. Unlike ethical drugs, the nutrition supplements market is dominated by domestic players but the recent restrictions imposed by the State Duma on the promotion of nutritional supplements have retarded the segment’s growth.
“Russian Pharma Sector Analysis (2007)” report does a comprehensive analysis of the Russian market, encompassing its demographics, structure of health care sector, size of pharma market, and comparative analysis of the market, among others. Also, a brief overview of the major players operating in the market has been given to present the competitive landscape of the market.
Key Issues Analyzed
- Where does the Russian pharmaceutical market stand in comparison to other key global markets? - What is the market size of various segments in the Russian pharmaceutical industry? - What is the proportion of domestic and imported drugs in each segment? - What are the opportunities that will emerge in future for the market?
Research Methodology Used
Information Sources
The information in the report has been taken from various credible sources like books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.
Analysis Methods
The analysis methods include ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting and cause and effect analysis.
For the purpose of this report, the Russian pharmaceutical market has been considered to consist of the following segments:
• The commercial drugs market; • The state segment (DLO program and hospital segment); and • The Parapharmaceutical segment (Food Supplements and Cosmetics).
The following currency conversion has been taken in the report: 1 Russian Ruble = US$ 0.039, 1 Euro = US$ 1.38
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today\'s globally competitive environment.
For more information visit: http://www.rncos.com/Report/IM548.htm Current Industry News: http://www.rncos.com/Blog/
2025
